ArticleMedicina (Kaunas, Lithuania)2026
Glycemic Outcomes After Switching from SGLT2 Inhibitors to DPP-4 Inhibitors in Type 2 Diabetes, with a Comparison of Teneligliptin and Other Agents: A Retrospective Cohort Study.
Joung Youl Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.